AbbVie 2014 Annual Report Download - page 137
Download and view the complete annual report
Please find page 137 of the 2014 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127 -
128 -
129 -
130 -
131 -
132 -
133 -
134 -
135 -
136 -
137 -
138 -
139 -
140 -
141 -
142 -
143 -
144 -
145 -
146 -
147 -
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
-
179
-
180
-
181
-
182
 |
 |
14FEB201503005075
13NOV201221352027
SECURITIES OWNERSHIP
Securities Ownership of Executive Officers and Directors
................................................................................................................................................................................................................................................................................................................................................................................................
The table below reflects the number of shares of AbbVie common stock beneficially owned as of January 31,
2015, by each director, the chief executive officer, the chief financial officer, and the three other most highly paid
executive officers (NEOs), and by all directors and executive officers of AbbVie as a group. It also reflects the number of
stock equivalent units and restricted stock units held by non-employee directors under the AbbVie Non-Employee
Directors’ Fee Plan.
R. Gonzalez 386,328 588,663 0
R. Alpern 13,858 0 3,887
R. Austin 28,365 0 0
W. Burnside 5,299 0 0
E. Liddy 10,420 0 11,963
E. Rapp 7,799 0 5,432
R. Roberts 25,299 0 0
G. Tilton 24,855 0 20,068
F. Waddell 7,299 0 0
C. Alban 245,580 198,287 0
W. Chase 180,980 205,034 0
L. Schumacher 272,797 394,293 0
M. Severino 141,625 0 0
All directors and executive officers as a group(4) 1,546,372 1,550,644 41,350
(1) The table includes shares held in the executive officers’ accounts in the AbbVie Savings Plan as follows: all executive
officers as a group, 1,738. Each executive officer has shared voting power and sole investment power with respect
to the shares held in his or her account.
(2) The table includes 1,650 restricted stock units held by the executive officers as a group. The table also includes
restricted stock units held by the non-employee directors. The directors’ units are payable in stock as described in
footnote (2) to the Director Compensation table.
(3) The table includes shared voting and/or investment power over shares as follows: G. Tilton, 350; C. Alban, 40,442;
W. Chase, 501; and all directors and executive officers as a group, 42,211.
(4) The directors and executive officers as a group together own less than one percent of the outstanding shares of
AbbVie.
2015 Proxy Statement 17
Stock Options
Shares Exercisable Stock
Beneficially within 60 days Equivalent
Name Owned(1)(2)(3) of January 31, 2015 Units